Nasdaq VRTX
Building the thesis tracking framework for Vertex Pharmaceuticals (VRTX) — which dimensions to watch, what counts as confirmation, what counts as deterioration. Takes about fifteen seconds; it appears here automatically.
Period ends Sep 30, 2026 · expected around Nov 3, 2026
Rows marked Latest are the SEC filing deadline for that report — the period end plus the number of days this company's filer status allows. Any “expected” date is our estimate from past filings, not a company announcement.
Major events from the past year, grouped by month · 5 items · 4 months · Routine governance filings are excluded; the full list is in the Filings tab.
Item 5.02 Departure or Election of Directors and Officers — Filed Sep 1, 2026 · event date Aug 27, 2026 · accession…
Vertex Pharmaceuticals filed a 10-Q (Quarterly Report) with the SEC.
Item 2.02 Results of Operations and Financial Condition · Item 9.01 Financial Statements and Exhibits — Filed Aug 3,…
Item 1.01 Entry into a Material Definitive Agreement · Item 7.01 Regulation FD Disclosure · Item 8.01 Other Events ·…
Item 5.02 Departure or Election of Directors and Officers · Item 5.07 Submission of Matters to a Vote of Security…
Tracks news from this company’s industry and its peers alongside its own.
Key figures · objective data, not a rating
End-of-day prices, delayed and not real-time · for reference only, not a rating and not investment advice